🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Material Elimination

According to the social media company, the service has taken down violative material and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, positive testimonials and detailed guides for mixing or administering at home.

Within moments of entering one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Within these groups, posts show black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.